Faculty

Computational chemist John Chodera uses statistical mechanics, molecular modeling, and automated biophysical experiments to help identify new potential therapeutics and investigate mechanisms of drug resistance in cancer.

• PhD, University of California, San Francisco

The Choi Lab develops new synthetic biology tools to study cell-fate decisions in development.

• PhD, Stanford University

Arvin Dar’s lab develops chemical tools and probes to explore disease mechanisms and the structural biology of cancer targets.

• PhD, University of Toronto, Toronto, Ontario

Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.

• Ph.D – The Weizmann Institute of Science
• B.Sc SUNY Stony Brook

The Kushal Dey lab focuses on developing machine learning models and computational pipelines that integrate genomic and epigenomic data.

• PhD, University of Chicago

The Diehl lab studies how the microbiota and other exogenous factors regulate development and function of the intestinal immune system.

• PhD, University of California, Berkeley

The Diver lab studies the physiological roles and molecular mechanisms of understudied membrane-embedded proteins with the goal of revealing novel therapeutic targets for diseases such as pain and cancer.

• BSc, Biochemistry, University of British Columbia (2007)
• PhD, Biochemistry and Structural Biology, Weill Cornell Graduate School of Medical Sciences (2015)
• Postdoc, University of California, San Francisco (2021)

My research involves the elucidation of genetic and biologic insights of human malignant lymphomas. We leverage large-scale unbiased profiling including genomics, transcriptomics, proteomics to identify candidate oncogenes and proteins that are pathogenetically relevant in lymphoma. We utilize molecular technologies, human tumor tissues and patient-derived xenografts and transgenic animal models to determine the functional significance of novel genes and proteins involved in lymphoma pathogenesis. Using primary tumors as our discovery models, the overall goal of our studies is to understand novel mechanisms of oncogenesis, identify tumor biomarkers and vulnerabilities that will facilitate early detection and precision therapies that improve patient outcomes.

• PhD, University of Laos and Lagos Teaching Hospital, Lagos, Nigeria

Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.

• MD, University of Buenos Aires School of Medicine (Argentina)

The Farese & Walther lab studies the biology and pathology of cellular lipid metabolism, focusing on lipid/energy storage in lipid droplets and sphingolipid metabolism in lysosomes.

• MD, Vanderbilt Medical School, Nashville, Tennessee